The significance of inflammatory markers in prognosticating the effectiveness and safety of immunotherapy in conjunction with chemotherapy during the primary intervention of advanced non-small cell lung carcinoma

医学 免疫疗法 化疗 肿瘤科 会合(天文学) 内科学 干预(咨询) 免疫学 癌症 物理 天文 精神科
作者
Zhen Wang,Xiaoxue Li,Jiahong Chen,Yin Hua,Xiaoqiang Zhong,Chunhui Tang,Sumin Gong,Ling Yang
出处
期刊:Lung Cancer [Elsevier]
卷期号:192: 107817-107817 被引量:4
标识
DOI:10.1016/j.lungcan.2024.107817
摘要

Objective The aim of this study is to scrutinize the prognostic significance of inflammatory biomarkers concerning the effectiveness and safety of combining PD-1 inhibition with chemotherapy in the management of advanced NSCLC. Methods We conducted a retrospective analysis involving 206 NSCLC patients who received treatment at Qingdao Municipal Hospital. The study encompassed the acquisition of baseline clinical attributes and hematological parameters of these patients. The optimal threshold values for PLT and NLR were ascertained based on pre-treatment evaluations, with a particular focus on their association with PFS. Variables linked to PFS were subject to scrutiny through Kaplan-Meier analysis and logistic regression. The Receiver Operating Characteristic (ROC) curve served as the means to determine the ideal cut-off values for categorizing levels of inflammatory markers into high and low classifications. We employed Chi-square tests to evaluate the relationship between elevated and reduced baseline levels of inflammatory markers and irAE. Results Kaplan-Meier analysis disclosed that patients in the low baseline PLT group and the low NLR group exhibited a substantially more favorable prognosis in contrast to their counterparts in the high baseline PLT and high NLR groups. Multivariate analysis indicated that diminished baseline PLT and NLR levels before treatment independently foretell extended PFS. Chi-square analysis underscored a substantial correlation between baseline WBC, NEUT, LYMPH, MONO, and NLR levels and irAE. Conclusion Subdued baseline PLT and NLR levels may serve as indicators of a more auspicious prognosis in patients contending with advanced NSCLC undergoing the combination of PD-1 inhibition and chemotherapy. Elevated baseline levels of inflammatory markers antedating PD-1 therapy in advanced NSCLC may be intimately interrelated with the occurrence of irAE.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
CR7应助科研通管家采纳,获得20
刚刚
隐形曼青应助科研通管家采纳,获得10
1秒前
英俊的铭应助科研通管家采纳,获得10
1秒前
wy.he应助科研通管家采纳,获得10
1秒前
Orange应助科研通管家采纳,获得80
1秒前
66677788完成签到,获得积分10
1秒前
orixero应助科研通管家采纳,获得10
1秒前
忧虑的梦槐完成签到,获得积分10
1秒前
1秒前
1秒前
Lucas应助科研通管家采纳,获得10
1秒前
利利发布了新的文献求助10
1秒前
SciGPT应助科研通管家采纳,获得10
1秒前
星辰大海应助科研通管家采纳,获得10
2秒前
2秒前
2秒前
2秒前
2秒前
2秒前
2秒前
2秒前
小蘑菇应助科研通管家采纳,获得30
2秒前
2秒前
2秒前
2秒前
Hello应助科研通管家采纳,获得10
2秒前
2秒前
2秒前
2秒前
完美世界应助科研通管家采纳,获得30
3秒前
今后应助科研通管家采纳,获得10
3秒前
汉堡包应助科研通管家采纳,获得10
3秒前
meo发布了新的文献求助10
3秒前
4秒前
shuyingRen发布了新的文献求助10
4秒前
huenguyenvan完成签到,获得积分10
5秒前
芝麻完成签到 ,获得积分10
6秒前
6秒前
Cherry发布了新的文献求助30
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Handbook of pharmaceutical excipients, Ninth edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6019542
求助须知:如何正确求助?哪些是违规求助? 7613857
关于积分的说明 16162427
捐赠科研通 5167341
什么是DOI,文献DOI怎么找? 2765629
邀请新用户注册赠送积分活动 1747427
关于科研通互助平台的介绍 1635638